Vident Investment Advisory, LLC / REGN
Vident Investment Advisory, LLC’s Regeneron Pharmaceuticals Position
Does Vident Investment Advisory, LLC own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 15.6K shares worth $11M in Q2 2023; the fund’s latest 13F (Q3 2023) no longer reports it.
Position Value
$11M
Q2 2023
Shares
15.6K
% of Portfolio
+0.39%
Quarters Held
19
position exited
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 15.6K | $11M | +0.39% |
| Q1 2023 | 20.3K | $17M | +0.54% |
| Q4 2022 | 18.6K | $13M | +0.51% |
| Q3 2022 | 8.8K | $6M | +0.19% |
| Q2 2022 | 18.7K | $11M | +0.33% |
| Q1 2022 | 9.0K | $6M | +0.16% |
| Q4 2021 | 13.6K | $9M | +0.22% |
| Q3 2021 | 16.0K | $10M | +0.29% |
| Q2 2021 | 12.9K | $7M | +0.22% |
| Q1 2021 | 14.5K | $7M | +0.23% |
| Q4 2020 | 9.7K | $5M | +0.19% |
| Q3 2020 | 8.3K | $5M | +0.23% |
| Q2 2020 | 7.8K | $5M | +0.25% |
| Q1 2020 | 7.8K | $4M | +0.23% |
| Q4 2019 | 4.5K | $2M | +0.10% |
| Q3 2019 | 4.9K | $1M | +0.12% |
| Q2 2019 | 5.1K | $2M | +0.13% |
| Q1 2019 | 4.4K | $2M | +0.10% |
| Q4 2018 | 4.5K | $2M | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vident Investment Advisory, LLC’s full portfolio or all institutional holders of REGN.